Bioxytran, Inc. (OTCQB: BIXT) is a clinical stage biotechnology company developing novel therapies targeting the treatment of significant unmet medical needs in virology, degenerative disease, and hypoxia.
Keynote speakers: Dr. David Platt, CEO & Mike Sheikh, Executive Vice President Business Development